|
|
Position:
Director of Business Development - We are seeking a motivated life scientist who can apply their scientific training and background in the management of existing and new business opportunities in the ADME-Tox field.
Employer:
Cyprotex
Description:
- Develop opportunities and close deals by understanding customer’s requirements, presenting and structuring a business and scientific framework and writing proposals to meet customer needs and to achieve business development objectives for the assigned territory.
- Coordinate and attend meetings, including virtual meetings, in person meetings, customer site visits and phone meetings, with current or potential customers, internal Company personnel and others to meet customer needs and to achieve revenue targets for the assigned territory.
- Build and maintain strong internal and external customer relationships, identifying current and future needs and aligning these with the capabilities and strategy of the business.
- Manage and execute the RFI/RFP processes including interactions with both sales and technical staff.
- Rapidly develop an in-depth understanding of Cyprotex’s products and services, and the impact that these have on customer projects at different stages of development.
- Drive additional revenue opportunities from within existing company relationships through targeted follow-ups, ensuring customers extract maximum value from current interactions.
- Answer web enquiries and follow up with contacts for other potential business development opportunities.
- New business development through prospecting of potential target customers.
- Attend Company meetings, key conferences and workshops.
- Maintain Cyprotex’s CRM (Salesforce)
Qualifications/Experience:
Location:
Field
Contact:
www.evotec.com
Post Date:
7/21/2020 12:00:00 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|